Sulbactam and Durlobactam (Xacduro)



  • Xacduro is a co-packaged product containing sulbactam, a beta-lactam antibiotic and beta-lactamse inhibitor, with durlobactam, a beta-lactamase inhibitor that is approved for use in patients 18 years of age and older for the management of hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) caused by susceptible strains of Acinetobacter species
    • Sulbactam/durlobactam only has activity against Acinetobacter species and should NOT be used for the treatment of HAP/VAP caused by other bacteria

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 12, 2023